Skip to content

Regulatory terminology

510(k) clearance, De Novo authorization, and FDA approval

Distinguish three FDA device pathways so that your research uses the right records and terminology.

By MedTech Watch editorial · Published Nov 19, 2026 · Sources checked Nov 19, 2026 · Updated Nov 19, 2026

510(k) clearance, De Novo classification, and PMA approval are different FDA pathways. Use the term and source that belong to the actual record; a 510(k)-only catalog does not cover every device authorization.

510(k): Clearance; De Novo: Classification request; PMA: Premarket approval
These labels describe different source records. The illustration is a research aid, not a pathway selection tool.

Use the pathway named by the source

“FDA approved” is not an interchangeable label for every device record. A 510(k) clearance, a granted De Novo request, and a premarket approval describe different regulatory processes. When summarizing a record, preserve the pathway and decision terminology used in the source.

For competitive research, this distinction changes where you search and what a count includes. A catalog of 510(k) clearances is not a complete inventory of every device authorized for the US market.

510(k): substantial equivalence

A 510(k) submission evaluates substantial equivalence to an appropriate legally marketed device. The resulting clearance record identifies the applicant, device, product code, and decision information. Read the linked source documents when the scope of a particular clearance matters.

MedTech Watch’s clearance pages are limited to qualifying 510(k) records. They do not relabel De Novo records returned by an upstream endpoint as clearances.

De Novo: a classification pathway

The De Novo pathway can establish a classification for a novel device for which there is no legally marketed predicate and for which the applicable controls can provide reasonable assurance of safety and effectiveness. Consult the FDA’s De Novo page and the individual decision for the specific circumstances.

A new classification can be relevant to the product codes you monitor. It does not mean that the De Novo decision itself should be counted as a 510(k) clearance.

PMA: premarket approval

Premarket approval is a separate process used for certain Class III devices. FDA’s PMA resources describe the evidence and review framework. A PMA identifier and its supplements belong to that record system, not to the 510(k) clearance list.

When comparing companies, state which pathways and dates are included. Otherwise a firm whose products use a different pathway may appear inactive simply because the search covers only 510(k)s.

Apply this distinction to your watchlist

Use product-code pages to understand the classification context, then check the underlying FDA sources. Public MedTech Watch research currently covers classification, qualifying 510(k) clearances, and recall records. Paid watchlists add relevant MAUDE reports. PMA and De Novo decision monitoring are not implied by that coverage.

This guide explains research terminology. It does not select the appropriate submission pathway for a particular new device.

Do not fill a missing clearance with an assumption

If an applicant has no matching record in the 510(k) view, first check the exact name and the search scope. The device may have a different pathway or an exemption; the absence of a match is not evidence that the device is unauthorized.

Follow the appropriate FDA pathway source before making a claim about a particular device. Our clearance counts exclude De Novo entries rather than relabeling them.

Sources

This guide explains public-record research and product behavior. See our editorial standards and data coverage.

Turn research into a documented team decision →

Useful context

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗